Status:
UNKNOWN
Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery
Lead Sponsor:
Assiut University
Conditions:
Cataract
Miosis
Eligibility:
All Genders
2-80 years
Phase:
PHASE2
Brief Summary
This study aim at determining the efficacy of Nepafenac and Ketorolac in obtaining adequate intraoperative mydriasis and preventing miosis during cataract surgery. It also compare the efficacy of both...
Detailed Description
Maintaining adequate mydriasis is one of the most important prerequisites during both extracapsular cataract extraction and phacoemulsification intervention. The importance of intraoperative maintenan...
Eligibility Criteria
Inclusion
- Patients with cataract who are candidate for cataract surgery
Exclusion
- D.M,
- Patient with other ocular comorbidities rather than cataract,
- Patients with history of trauma.
- Patients on Corticosteroid drops treatment.
- Previous intraocular surgery.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2020
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03851172
Start Date
March 1 2019
End Date
March 30 2020
Last Update
February 25 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.